Investing Center Preview – Manage your investments and watch your net worth grow.
ICLR:NASDAQ – Large Cap Stock (Diagnostics & Research)
ICON PLC – ICLR Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
167.89 | 6.39 (+3.96%) | 125.10 - 339.89 | 2.9 million (Above Avg) |
Market data as of 3:59PM 07/23/25. Quotes are delayed by at least 15 min.
Overview - ICLR
Open | 166.04 |
---|---|
Previous Close | 161.50 |
Day's Range | 161.96 - 170.73 |
Market Cap | 13.6B |
Avg Volume (10 Day) | 1.8M |
Price/Earnings (Trailing 12 Mo.) | 15.2x |
Earnings Per Share (Trailing 12 Mo.) | 2.531 |
Dividend Yield | No Dividend |
One-Click Scorecard - ICLR


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Fail |
Increased shareholder value? | Fail |
Consistently increased owner earnings? | Pass |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Neutral |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Fail |
Stock is undervalued? | Fail |
Have investors caught on? | Fail |
Has support of institutional investors? | Pass |
Has sufficient liquidity? | Pass |
Latest Headlines - ICLR
ICON Announces Results of Annual General Meeting
Business Wire - Wednesday 07/23/2025 4:20 PM ET
ICON Reports Second Quarter 2025 Results
Business Wire - Wednesday 07/23/2025 4:15 PM ET
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
Business Wire - Wednesday 07/16/2025 7:15 AM ET
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
Business Wire - Monday 07/07/2025 7:15 AM ET
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
Business Wire - Monday 06/23/2025 6:30 AM ET
Industry Position - ICLR
ICLR | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 1.99% | |
Net Income Growth (1yr) | 29.26% | |
Total Debt/Equity | 0.37 | |
LT Debt/Equity | 0.37 | |
Earnings Yield | 6.57% | |
Price/Sales | 1.41 |
Competitors - ICLR
Company | Last | Change |
---|---|---|
Medpace Holdings Inc | 437.41 | -8.44% |
29.75 | +2.09% | |
122.00 | +2.43% | |
Revvity Inc | 99.45 | +3.45% |
18.56 | +2.43% |
Data is delayed by at least 15 min.